Long-term results after sleeve gastrectomy: A systematic review

Juodeikis, Žygimantas; Brimas, Gintautas

doi:10.1016/j.soard.2016.10.006

Cited by 118 publications

(58 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, there are hardly any studies on how patients’ QOL develops over a longer period of time. Juodeikis and Brimas [8], who reviewed current long-term studies on SG, concludes that there are few data available on QOL after SG. He therefore recommends treating the existing data with caution.…”

Section: Introductionmentioning

confidence: 99%

Quality of Life 10 Years after Sleeve Gastrectomy: A Multicenter Study

et al. 2019

View full text Add to dashboard Cite

Objective: Sleeve gastrectomy (SG) has recently become the most commonly applied bariatric procedure worldwide. Substantial regaining of weight or severe reflux might compromise quality of life (QOL) after SG in the long-term follow-up. Long-term data on patients’ QOL is limited, even though the persistent improvement in QOL is one of the aims of bariatric surgery. The objective of this study was to present patients’ QOL 10 years after SG. Methods: Of 65 SG patients with a follow-up of ≥10 years after SG who were asked to fill out the Bariatric Quality of Life Index (BQL) and Short Form 36 (SF36) questionnaires, 48 (74%) completed them. This multicenter study was performed in a university hospital setting in Austria. Results: The BQL score revealed nonsignificant differences between the patients with > 50% or < 50% excess weight loss (EWL). It did show significant differences between patients with and without any symptoms of reflux. Patients with < 50% EWL scored significantly lower in 3/8 categories of SF36. Patients suffering from reflux had significantly lower scores in all categories. Conclusions: EWL and symptomatic reflux impair patients’ long-term QOL after SG.

show abstract

Section: Introductionmentioning

confidence: 99%

Quality of Life 10 Years after Sleeve Gastrectomy: A Multicenter Study

et al. 2019

View full text Add to dashboard Cite

show abstract

“…In another study, there were no significant differences in terms of fasting glucose and insulin levels between patients who underwent LSG and those who underwent duodenal switch or gastric bypass [27]. In a retrospective study, 2713 patients were screened and 77.8% of obese patients with T2DM demonstrated improvement as they discontinued the medication or reduced drug dosage after bariatric surgery [28]. In a retrospective study involving over 2000 bariatric surgical operations, 85% of patients who used OAD preoperatively discontinued medication at the end of postoperative 2 years [29].…”

Section: Discussionmentioning

confidence: 99%

Laparoskopic sleeve gastrektomi'nin kısa ve orta dönem sonuçları, tip 2 diyabet ve hipertansiyona etkileri

Baştürk¹,

Birsen²,

Baştürk³

2020

Pamukkale Medical Journal

View full text Add to dashboard Cite

show abstract

“…Globally, the evidence for long-term outcomes after SG as a primary procedure is building, with multiple studies presenting positive outcomes of comorbidity improvement and persistent weight loss beyond 5 years following surgery. 20,21 There is a need to examine the application of SG in Canada to determine whether the current standard of care can be improved, drawing on outcomes that have been achieved in other locations for a sense of what may be feasible.…”

Section: Introductionmentioning

confidence: 99%

Comparison of Comorbidity Treatment and Costs Associated With Bariatric Surgery Among Adults With Obesity in Canada

Davis

Saunders

2020

JAMA Netw Open

View full text Add to dashboard Cite

IMPORTANCE Information on the associations between barriers to delivery of bariatric surgery and poor weight trajectory afterward is lacking. Estimates are needed to inform decisions by administrators and clinicians to improve care. OBJECTIVE To estimate the difference in patient-years of treatment for diabetes, hypertension, and dyslipidemia and public-payer cost between the Canadian standard and an improved bariatric surgery care pathway. DESIGN, SETTING, AND PARTICIPANTS Economic evaluation of a decision analytic model comparing the outcomes of the standard care in Canada with an improved bariatric care pathway with earlier sleeve gastrectomy delivery and better postsurgical weight trajectory. The model was informed by published clinical data (101 studies) and meta-analyses (11 studies) between January and May 2019. Participants were a hypothetical 100-patient cohort with demographic characteristics derived from a Canadian study. INTERVENTIONS Reduction of Canadian mean bariatric surgery wait time by 2.5 years following referral and improvement of patient postsurgery weight trajectory to levels observed in other countries. MAIN OUTCOMES AND MEASURES Modeling weight trajectory after sleeve gastrectomy and resolution rates for comorbidities in Canada in comparison with an improved care pathway to estimate differences in patient-years of comorbidity treatment over 10 years following referral and the associated costs. RESULTS For the 100-patient cohort (mean [SD] 88.2% [1.4%] female; mean [SD] age, 43.6 [9.2] years; mean [SD] body mass index, 49.4 [8.2]; and mean [SD] comorbidity prevalence of 50.0% [4.1%], 66.0% [3.9%], and 59.3% [4.0%] for diabetes, hypertension, and dyslipidemia, respectively) over 10 years following referral, the improved vs standard care pathway was associated with median reduction in patient-years of treatment of 324 (95% credibility interval [CrI], 249-396) for diabetes, 245 (95% CrI, 163-356) for hypertension, and 255 (95% CrI, 169-352

show abstract

Long-term results after sleeve gastrectomy: A systematic review

Cited by 118 publications

References 38 publications

Quality of Life 10 Years after Sleeve Gastrectomy: A Multicenter Study

Quality of Life 10 Years after Sleeve Gastrectomy: A Multicenter Study

Laparoskopic sleeve gastrektomi'nin kısa ve orta dönem sonuçları, tip 2 diyabet ve hipertansiyona etkileri

Comparison of Comorbidity Treatment and Costs Associated With Bariatric Surgery Among Adults With Obesity in Canada

Contact Info

Product

Resources

About